Vincent J. Colandrea, Ph.D. - Publications

Affiliations: 
2002 Rutgers University, New Brunswick, New Brunswick, NJ, United States 
Area:
Organic Chemistry

16 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Wilson JE, Kurukulasuriya R, Reibarkh M, Reiter M, Zwicker A, Zhao K, Zhang F, Anand R, Colandrea VJ, Cumiskey AM, Crespo A, Duffy RA, Murphy BA, Mitra K, Johns DG, et al. Discovery of Novel Indoline Cholesterol Ester Transfer Protein Inhibitors (CETP) through a Structure-Guided Approach. Acs Medicinal Chemistry Letters. 7: 261-5. PMID 26985312 DOI: 10.1021/acsmedchemlett.5b00404  0.68
2016 Neelamkavil SF, Agrawal S, Bara T, Bennett C, Bhat S, Biswas D, Brockunier L, Buist N, Burnette D, Cartwright M, Chackalamannil S, Chase R, Chelliah M, Chen A, Clasby M, ... Colandrea VJ, et al. Discovery of MK-8831, A Novel Spiro-Proline Macrocycle as a Pan-Genotypic HCV-NS3/4a Protease Inhibitor. Acs Medicinal Chemistry Letters. 7: 111-6. PMID 26819676 DOI: 10.1021/acsmedchemlett.5b00425  0.68
2012 Vachal P, Miao S, Pierce JM, Guiadeen D, Colandrea VJ, Wyvratt MJ, Salowe SP, Sonatore LM, Milligan JA, Hajdu R, Gollapudi A, Keohane CA, Lingham RB, Mandala SM, DeMartino JA, et al. 1,3,8-Triazaspiro[4.5]decane-2,4-diones as efficacious pan-inhibitors of hypoxia-inducible factor prolyl hydroxylase 1-3 (HIF PHD1-3) for the treatment of anemia. Journal of Medicinal Chemistry. 55: 2945-59. PMID 22364528 DOI: 10.1021/jm201542d  0.68
2010 Yan L, Colandrea VJ, Hale JJ. Prolyl hydroxylase domain-containing protein inhibitors as stabilizers of hypoxia-inducible factor: small molecule-based therapeutics for anemia. Expert Opinion On Therapeutic Patents. 20: 1219-45. PMID 20698812 DOI: 10.1517/13543776.2010.510836  0.68
2009 Du W, Jewell JP, Lin LS, Colandrea VJ, Xiao JC, Lao J, Shen CP, Bateman TJ, Reddy VB, Ha SN, Shah SK, Fong TM, Hale JJ, Hagmann WK. Synthesis and evaluation of N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-aminopropanamide as human cannabinoid-1 receptor (CB1R) inverse agonists. Bioorganic & Medicinal Chemistry Letters. 19: 5195-9. PMID 19632830 DOI: 10.1016/j.bmcl.2009.07.046  0.68
2007 Armstrong HE, Galka A, Lin LS, Lanza TJ, Jewell JP, Shah SK, Guthikonda R, Truong Q, Chang LL, Quaker G, Colandrea VJ, Tong X, Wang J, Xu S, Fong TM, et al. Substituted acyclic sulfonamides as human cannabinoid-1 receptor inverse agonists. Bioorganic & Medicinal Chemistry Letters. 17: 2184-7. PMID 17293109 DOI: 10.1016/j.bmcl.2007.01.087  0.68
2006 Colandrea VJ, Legiec IE, Huo P, Yan L, Hale JJ, Mills SG, Bergstrom J, Card D, Chebret G, Hajdu R, Keohane CA, Milligan JA, Rosenbach MJ, Shei GJ, Mandala SM. 2,5-Disubstituted pyrrolidine carboxylates as potent, orally active sphingosine-1-phosphate (S1P) receptor agonists. Bioorganic & Medicinal Chemistry Letters. 16: 2905-8. PMID 16580205 DOI: 10.1016/j.bmcl.2006.03.038  0.68
2003 Colandrea VJ, Rajaraman S, Jimenez LS. Synthesis of the mitomycin and FR900482 ring systems via dimethyldioxirane oxidation. Organic Letters. 5: 785-7. PMID 12633071 DOI: 10.1021/ol026738y  0.68
2002 Stearns RA, Miller RR, Tang W, Kwei GY, Tang FS, Mathvink RJ, Naylor EM, Chitty D, Colandrea VJ, Weber AE, Colletti AE, Strauss JR, Keohane CA, Feeney WP, Iliff SA, et al. The pharmacokinetics of a thiazole benzenesulfonamide beta 3-adrenergic receptor agonist and its analogs in rats, dogs, and monkeys: improving oral bioavailability. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 30: 771-7. PMID 12065435 DOI: 10.1124/dmd.30.7.771  0.68
2000 Biftu T, Feng DD, Liang GB, Kuo H, Qian X, Naylor EM, Colandrea VJ, Candelore MR, Cascieri MA, Colwell LF, Forrest MJ, Hom GJ, MacIntyre DE, Stearns RA, Strader CD, et al. Synthesis and SAR of benzyl and phenoxymethylene oxadiazole benzenesulfonamides as selective beta3 adrenergic receptor agonist antiobesity agents. Bioorganic & Medicinal Chemistry Letters. 10: 1431-4. PMID 10888325 DOI: 10.1016/S0960-894X(00)00268-7  0.68
2000 Colandrea VJ, Naylor EM. Synthesis and regioselective alkylation of 1,6- and 1,7-naphthyridines Tetrahedron Letters. 41: 8053-8057.  0.68
1999 Naylor EM, Parmee ER, Colandrea VJ, Perkins L, Brockunier L, Candelore MR, Cascieri MA, Colwell LF, Deng L, Feeney WP, Forrest MJ, Hom GJ, MacIntyre DE, Strader CD, Tota L, et al. Human beta3 adrenergic receptor agonists containing imidazolidinone and imidazolone benzenesulfonamides. Bioorganic & Medicinal Chemistry Letters. 9: 755-8. PMID 10201842 DOI: 10.1016/S0960-894X(99)00072-4  0.68
1999 Parmee ER, Naylor EM, Perkins L, Colandrea VJ, Ok HO, Candelore MR, Cascieri MA, Deng L, Feeney WP, Forrest MJ, Hom GJ, MacIntyre DE, Miller RR, Stearns RA, Strader CD, et al. Human beta3 adrenergic receptor agonists containing cyclic ureidobenzenesulfonamides. Bioorganic & Medicinal Chemistry Letters. 9: 749-54. PMID 10201841 DOI: 10.1016/S0960-894X(99)00073-6  0.68
1999 Wang Y, Zhang W, Colandrea VJ, Jimenez LS. Reactivity and rearrangements of dialkyl- and diarylvinylsulfonium salts with indole-2- and pyrrole-2-carboxaldehydes Tetrahedron. 55: 10659-10672. DOI: 10.1016/S0040-4020(99)00605-5  0.68
1998 Naylor EM, Colandrea VJ, Candelore MR, Cascieri MA, Colwell LF, Deng L, Feeney WP, Forrest MJ, Hom GJ, MacIntyre DE, Strader CD, Tota L, Wang PR, Wyvratt MJ, Fisher MH, et al. 3-Pyridylethanolamines: potent and selective human beta 3 adrenergic receptor agonists. Bioorganic & Medicinal Chemistry Letters. 8: 3087-92. PMID 9873681 DOI: 10.1016/S0960-894X(98)00571-X  0.68
1994 Godfrey JD, Mueller RH, Sedergran TC, Soundararajan N, Colandrea VJ. Improved synthesis of aryl 1,1-dimethylpropargyl ethers Tetrahedron Letters. 35: 6405-6408. DOI: 10.1016/S0040-4039(00)78231-1  0.68
Show low-probability matches.